1 | Acetylcysteine | Acetylcysteine 12件: Acetylcysteine; Acetylcysteine effervescent tablets; Acetylcysteine sodium; Fluimucil (acetylcysteine); Glatiramer acetate, n-acetylcysteine; Jaktinib dihydrochloride monohydrate 50mg bid and mimic tablets of jakitinib hydrochloride 75mg bid and acetylcysteine effervescent tablets; Jaktinib dihydrochloride monohydrate 75mg bid and mimic tablets of jakitinib hydrochloride 50mg bid and acetylcysteine effervescent tablets; N acetylcysteine; N-acetylcysteine; N-acetylcysteine (nac); N-acetylcysteine capsule; N-acetylcysteine, (nac); | 1件: D00221 D00221 💬 |
- |
- |
006 17件: 6 , 13, 19, 20, 34, 49, 51, 58, 85, 90, 94, 111, 164, 193, 233, 298, 299 💬 |
2 | Anastrozole | Anastrozole 2件: Anastrozole; Arimidex (anastrozole); | 1件: D00960 D00960 💬 |
1件: CYP19A1 💬 |
Metabolic pathways 3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis |
078 3件: 78, 86, 193 💬 |
3 | Beloranib | Beloranib 2件: Beloranib; Subcutaneous beloranib in suspension; | - |
- |
- |
193 1件: 193 💬 |
4 | Cannabidiol | Avcn583601 (3% cannabidiol cream) 11件: Avcn583601 (3% cannabidiol cream); Cannabidiol; Cannabidiol (cbd); Cannabidiol , synthetic form; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Cannabidiol botanical drug substance (cbd bds); Cannabidiol capsule 5 mg; Cannabidiol oral solution; Cannabidiol tablet 10 mg; Cannabidiol vaginal suppository; Delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd); | 1件: D10915 D10915 💬 |
2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 19件: 2 , 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 |
5 | Cannabidivarin | - | - |
- |
- |
193 1件: 193 💬 |
6 | Carbetocin | Carbetocin 3件: Carbetocin; Intranasal carbetocin dose 1; Intranasal carbetocin dose 2; | 1件: D07229 D07229 💬 |
1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 1件: 193 💬 |
7 | Chloride ion | - | - |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
8 | Choline | Bis-choline tetrathiomolybdate 11件: Bis-choline tetrathiomolybdate; Choline; Choline chloride; Choline supplementation; Diazoxide choline; Diazoxide choline controlled-release tablet; Rhudex 100 mg (127 mg rhudex choline salt) granules; Rhudex 25 mg (31.75 mg rhudex choline salt) granules; Rhudex 50 mg (63.5 mg rhudex choline salt) granules; Rhudex choline salt; Vitamin: choline bitartrate (2-hydroxyethyl) trimethylammonium salt 1:1; | 1件: D07690 D07690 💬 |
- |
- |
093 4件: 93, 171, 193, 299 💬 |
9 | Corticotropin | Adrenocorticotropin hormone 8件: Adrenocorticotropin hormone; Corticotropin; Corticotropin-releasing hormone; H.p. acthar gel (repository corticotropin injection); Other: corticotropin releasing hormone (crh); Ovine corticotropin-releasing hormone (ocrh); Repository corticotropin injection; Repository corticotropin injection -treatment extension; | 1件: D00146 D00146 💬 |
1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 13件: 2 , 13, 14, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 💬 |
10 | Diazoxide | Diazoxide 3件: Diazoxide; Diazoxide choline; Diazoxide choline controlled-release tablet; | 1件: D00294 D00294 💬 |
2件: ABCC8, KCNJ11 💬 |
ABC transporters 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
013 2件: 13, 193 💬 |
11 | Exenatide | Exenatide 5件: Exenatide; Exenatide 10 micrograms; Exenatide 5 micrograms; Exenatide extended release 2mg (bydureon); Exenatide pen injector [bydureon]; | 1件: D04121 D04121 💬 |
1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 4件: 6 , 17, 193, 233 💬 |
12 | Guanfacine | Guanfacine 2件: Guanfacine; Guanfacine extended release (gxr); | 2件: D00606 D00606
D08031 D08031 💬 |
1件: ADRA2A 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
193 1件: 193 💬 |
13 | Liraglutide | Liraglutide 1件: Liraglutide; | 1件: D06404 D06404 💬 |
1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 3件: 6 , 75, 193 💬 |
14 | Livoletide | Livoletide 1件: Livoletide; | - |
- |
- |
193 1件: 193 💬 |
15 | Medical air | Medical air 5件: Medical air; Medical air (sham o2); Medical air vs oxygen; Other: medical air; Sham o2 (medical air); | - |
- |
- |
003 8件: 3 , 51, 58, 85, 86, 97, 193, 299 💬 |
16 | Metoprolol | Metoprolol 8件: Metoprolol; Metoprolol succinate; Metoprolol succinate + doxazosin; Metoprolol tartrate 50 mg; Metoprolol tartrate oral tablet; Metoprololsuccinat orion 25mg; Metoprololsuccinat ”orion” 25mg; Tesofensine/metoprolol; | 3件: D00601 D00601
D02358 D02358
D05011 D05011 💬 |
1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 6件: 17, 57, 58, 113, 193, 226 💬 |
17 | Metyrapone | Metyrapone 2件: Metyrapone; Other: overnight metyrapone test; | 2件: D00410 D00410
D05019 D05019 💬 |
1件: CYP11B1 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis |
075 2件: 75, 193 💬 |
18 | Octreotide | Gallium-68-dota-n-octreotide 6件: Gallium-68-dota-n-octreotide; Octreotide; Octreotide acetate; Octreotide lar; Octreotide lar / sandostatin lar (lar=long acting release); Octreotide-lar; | 2件: D00442 D00442
D06495 D06495 💬 |
1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 7件: 67, 75, 84, 85, 89, 193, 227 💬 |
19 | Oxygen | Behavioral: respiratory and exercise therapy with supplemental oxygen 39件: Behavioral: respiratory and exercise therapy with supplemental oxygen; Combination product: hyperbaric oxygen therapy-; Continuous oxygen; Device: auto-titrating oxygen system; Device: capacity of muscular oxygen extraction; Device: high flow nasal oxygen cannula; Device: hyperbaric oxygen; Device: intermittent exposure to oxygen via oro-nasal mask; Device: nocturnal oxygen , nocturnal bi-level positive pressure ventilation; Device: oxygen; Device: oxygen saturation; Device: standard oxygen therapy/ra; Diagnostic test: maximum oxygen uptake; Helium / oxygen mixed gas inhalation therapy; Medical air vs oxygen; Medical grade oxygen; Nitric oxide plus oxygen; Other: 60% oxygen; Other: air - oxygen; Other: hyperbaric oxygen; Other: hyperbaric oxygen therapy; Other: muscle oxygenation; Other: optional blood-oxygen-level dependent functionalmri; Other: oxygen; Other: oxygen (2liter/min); Other: oxygen (4liter/min); Other: oxygen - air; Other: oxygen supplementation; Oxygen; Oxygen 40 %; Oxygen supplementation; Oxygen, liquid; Perfluorinated gas/oxygen mixture; Procedure: hyperbaric oxygen; Procedure: hyperbaric oxygen therapy; Procedure: long term oxygen therapy; Procedure: oxygen flow at the optic nerve head measurement; Procedure: supplemental oxygen via a mask; Standard analgesia use [oxygen]; | 1件: D00003 D00003 💬 |
- |
- |
006 18件: 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
20 | Oxytocin | Intranasal oxytocin 8件: Intranasal oxytocin; Intranasal oxytocin (in-oxt); Oxytocin; Oxytocin (oxt) continuous; Oxytocin 24iu; Oxytocin 48iu; Oxytocin synthetic; Synthetic oxytocin; | 1件: D00089 D00089 💬 |
1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
006 5件: 6 , 127, 193, 206, 226 💬 |
21 | Pitolisant | Bf2.649 (pitolisant) 3件: Bf2.649 (pitolisant); Pitolisant; Pitolisant oral tablets; | 1件: D10749 D10749 💬 |
1件: HRH3 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 2件: 6 , 193 💬 |
22 | Rimonabant | Rimonabant 1件: Rimonabant; | 1件: D05731 D05731 💬 |
1件: CNR1 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
193 1件: 193 💬 |
23 | Sodium chloride | 0.9% sodium chloride 24件: 0.9% sodium chloride; 0.9% sodium chloride (normal saline); 0.9% sodium chloride injection; 0.9% w/v isotonic sodium chloride solution; 0.9% w/v sodium chloride solution; Isotonic sodium chloride solution; Other: 0.9% sodium chloride; Other: 0.9ml sodium chloride; Other: sodium chloride; Physiological serum (sodium chloride); Procedure: 9% sodium chloride (nacl) iv; Sodium chloride; Sodium chloride (7%); Sodium chloride 0,9%; Sodium chloride 0.9%; Sodium chloride 6%; Sodium chloride 7%; Sodium chloride ph. eur.; Sodium chloride solution; Sodium chloride solution 0.9%; Sodium chloride solvent; Sodium pyruvate in 0.9% sodium chloride solution; Solucion de cloruro de sodio sodium chloride solution; Solvente cloruro de sodio sodium chloride solvent; | 1件: D02056 D02056 💬 |
- |
- |
006 20件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
24 | Somatotropin | Recombinant human somatotropin 3件: Recombinant human somatotropin; Somatotropin; Somatotropine; | 1件: D02691 D02691 💬 |
1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 20件: 2 , 3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬 |
25 | Tesofensine | 1. tesofensine (ns 2330) 3件: 1. tesofensine (ns 2330); Tesofensine; Tesofensine/metoprolol; | - |
- |
- |
006 2件: 6 , 193 💬 |
26 | Topiramate | Topiramate 2件: Topiramate; Topiramate (drug); | 1件: D00537 D00537 💬 |
36件: CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 52件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 5件: 6 , 140, 144, 156, 193 💬 |
27 | Ubidecarenone | - | 1件: D01065 D01065 💬 |
- |
- |
002 13件: 2 , 5 , 6 , 8 , 10, 18, 46, 57, 86, 113, 193, 214, 215 💬 |